Skip to main content
. 2021 Jan 7;21:24. doi: 10.1186/s12872-020-01839-w

Fig. 1.

Fig. 1

Predictive value of FGF-23 for 2-year ISR risk. Comparison of FGF-23 expression between 2-year non-ISR patients and 2-year ISR patients (a). Ability of FGF-23 in predicting 2-year ISR risk in CHD patients treated by PCI with DES (b). FGF-23 fibroblast growth factor 23, ISR in-stent restenosis, PCI percutaneous coronary intervention, DES drug-eluting stent, CHD coronary heart disease, AUC area under the curve, CI confidence interval